|
CN102869679A
|
|
Stable MIA/CD-RAP formulation
|
|
BRPI0816784A2
|
|
Neuroendocrine factors for the treatment of degenerative diseases
|
|
CN102940878A
|
|
Spinal nucleus pulposus implant
|
|
EP2036921A1
|
|
Use of Slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases
|
|
WO2007068489A2
|
|
A moldable biomaterial for bone regeneration
|
|
EP1872807A1
|
|
Biomaterial containing degradation stabilized polymer
|
|
EP1753396A2
|
|
Composite material for use as protein carrier
|
|
CN1938194A
|
|
Coated implants, their manufacturing and use thereof
|
|
EP1604694A1
|
|
Composite device having osteoinductive and osteoconductive properties
|
|
EP1604649A1
|
|
Composite material for use as protein carrier
|
|
EP1604693A1
|
|
In situ forming scaffold, its manufacturing and use
|
|
CN1681540A
|
|
Metal implant coated under reduced oxygen concentration with osteoinductive protein
|
